Lundgren H - Search Results

1

HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity.

Lundgren H, Martinsson K, Cederbrant K, Jirholt J, Mucs D, Madeyski-Bengtson K, Havarinasab S, Hultman P. Lundgren H, et al. PLoS One. 2017 Sep 21;12(9):e0184744. doi: 10.1371/journal.pone.0184744. eCollection 2017. PLoS One. 2017. PMID: 28934241 Free PMC article.

2

A triple-transgenic immunotolerant mouse model.

Brenden N, Madeyski-Bengtson K, Martinsson K, Svärd R, Albery-Larsdotter S, Granath B, Lundgren H, Lövgren A. Brenden N, et al. Among authors: lundgren h. J Pharm Sci. 2013 Mar;102(3):1116-24. doi: 10.1002/jps.23447. Epub 2013 Jan 11. J Pharm Sci. 2013. PMID: 23316010 Free PMC article.

3

Tesaglitazar, a dual PPAR-α/γ agonist, hamster carcinogenicity, investigative animal and clinical studies.

Lindblom P, Berg AL, Zhang H, Westerberg R, Tugwood J, Lundgren H, Marcusson-Ståhl M, Sjögren N, Blomgren B, Öhman P, Skånberg I, Evans J, Hellmold H. Lindblom P, et al. Among authors: lundgren h. Toxicol Pathol. 2012;40(1):18-32. doi: 10.1177/0192623311429972. Epub 2011 Nov 30. Toxicol Pathol. 2012. PMID: 22131108

4

Making decisions "in the dark": Learning through uncertainty in clinical practice during Covid-19.

Vaid U, Lundgren H, Watkins KE, Ziring D, Alcid GA, Marsick VJ, Papanagnou D. Vaid U, et al. Among authors: lundgren h. AEM Educ Train. 2023 Oct 2;7(5):e10909. doi: 10.1002/aet2.10909. eCollection 2023 Oct. AEM Educ Train. 2023. PMID: 37791137 Free PMC article.

5

Informal and Incidental Learning in the Clinical Learning Environment: Learning Through Complexity and Uncertainty During COVID-19.

Papanagnou D, Watkins KE, Lundgren H, Alcid GA, Ziring D, Marsick VJ. Papanagnou D, et al. Among authors: lundgren h. Acad Med. 2022 Aug 1;97(8):1137-1143. doi: 10.1097/ACM.0000000000004717. Epub 2022 Jul 21. Acad Med. 2022. PMID: 35476789 Free PMC article.

6

A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M.

Anan I, Bång J, Lundgren HE, Wixner J, Westermark P. Anan I, et al. Among authors: lundgren he. Amyloid. 2019;26(sup1):29-30. doi: 10.1080/13506129.2019.1593132. Amyloid. 2019. PMID: 31343355 No abstract available.

7

The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition.

Wixner J, Westermark P, Ihse E, Pilebro B, Lundgren HE, Anan I. Wixner J, et al. Among authors: lundgren he. Amyloid. 2019;26(sup1):39-40. doi: 10.1080/13506129.2019.1593133. Amyloid. 2019. PMID: 31343354 Free article. Clinical Trial. No abstract available.

8

Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.

Hellman U, Lång K, Ihse E, Jonasson J, Olsson M, Lundgren HE, Pilebro B, Westermark P, Wixner J, Anan I. Hellman U, et al. Among authors: lundgren he. Scand J Clin Lab Invest. 2019 Oct;79(6):372-376. doi: 10.1080/00365513.2019.1624977. Epub 2019 Jun 6. Scand J Clin Lab Invest. 2019. PMID: 31169435 Free article.

9

Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.

Suhr OB, Wixner J, Anan I, Lundgren HE, Wijayatunga P, Westermark P, Ihse E. Suhr OB, et al. Among authors: lundgren he. PLoS One. 2019 Feb 27;14(2):e0211983. doi: 10.1371/journal.pone.0211983. eCollection 2019. PLoS One. 2019. PMID: 30811423 Free PMC article.

10

Satsa på Cochrane i Sverige.

Axelsson I, Petersson I, Garwicz M, Lundgren H. Axelsson I, et al. Among authors: lundgren h. Lakartidningen. 2018 Sep 24;115:FCSI. Lakartidningen. 2018. PMID: 30252121 Free article. Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters